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Abstract
Background Among 40 patients with primary malignant
tumors of the knee joint who underwent reconstruction of
the aVected limb with tumor prosthesis, revision was
required in 7 due to stem breakage or loosening.
Subjects and methods In the 7 cases undergoing revision,
conditions and background factors at the time of breakage,
the breakage site, time of revision, models of previous and
new prostheses, stem diameters before and after revision,
details of the revision (blood loss, operative time), and the
presence or absence of adjuvant therapy were determined.
Results The replacement site was the distal femur in 5 and
proximal tibia in 2. Revision was performed 6 years and
2 months after the previous prosthesis placement on aver-
age. The broken prosthesis model was KMFTR in 4 and
HMRS and the physio-hinge type in one each. Revision due
to loosening was performed in a case requiring replacement
with Growing Kotz prosthesis. The model was switched to
HMRS in 3, and the stem diameter was changed to 12 mm
in 3 KMFTR breakage cases. The mean stem diameters
were 11.2 and 10.2 mm in the non-revision and revision
groups. The respective resection rates were 36 and 45%.
The mean functional evaluation was 70.1% before and
76.2% after revision.
Conclusion To reduce the risk of tumor prosthesis break-
age, the amount of bone resection should be limited to 30%
or less in the aVected bone, the stem diameter should be at
least 12 mm, and the stem shape should be Wtted to the ana-
tomical shape of the femur.
Keywords Limb salvage · Revision · Tumor prostheses · 
Malignant bone tumor
Background
Various methods, such as allografting [1, 2], pasteurized
autografting [3], and bone elongation [4], have recently
been employed for the reconstruction of limbs aVected by
malignant bone tumors. However, reconstruction with
tumor prosthesis remains the primary treatment. Tumor
prosthesis use is advantageous in that it facilitates stable
function of the aVected limb and an early return to social
activities. The survival rate of patients treated with tumor
prosthesis was satisfactory in a recent report [5]. However,
there are potentially serious complications, including infec-
tion, breakage, and loosening. We recently experienced a
case in which tumor prosthesis of the knee joint (Howmedica
Modular Reconstruction System (HRMS) broke 13 years after
surgery. Reportedly, tumor prostheses breakage is caused
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by increased patient activity and loosening of the stem.
When wide resection is performed for a malignant bone
tumor around the knee joint, the surrounding soft tissue is
also resected. Thus, a hinge-type prosthesis is inevitably
needed to stabilize the knee joint. Breakage of the stem is
thus reportedly due to the design of the prosthesis [5]. The
causes of breakage are thought to include the stem diame-
ter, the length of resected bone, and prosthesis design.
Forty patients with primary malignant tumors around the
knee joint underwent limb salvage by reconstruction with
prosthesis use. To investigate the causes underlying break-
age of prostheses, we divided these patients into those with
(7) and without (33) revision of a broken or loose stem. The
prosthesis model, stem diameter, length of resected bone,
and International Symposium on Limb Salvage (ISOLS)
X-ray evaluation were determined in each case. In the 7
revision cases, elements assumed to be causative were
analyzed in detail to identify problems and possible coun-
termeasures.
Materials and methods
The 40 subjects had primary malignant tumors of the
knee joint and underwent limb salvage by reconstruction
with a prosthesis in our department between 1979 and
2008.
The subjects comprised 20 women and 20 men, ranging
in age from 7 to 82 years (mean age, 27.5 years). The path-
ological diagnosis of the primary lesion was osteosarcoma
in 28, chondrosarcoma in 5, bone malignant Wbrous histio-
cytoma (MFH) in 3, and a giant cell tumor GCT (grade 3),
synovial sarcoma, Ewing’s sarcoma, and a primitive neu-
roectodermal tumor (PNET)in one each. The duration of
follow-up ranged from 1 year and 5 months to 19 years
(mean: 11 years and 2 months). The 7 patients who under-
went replacement were 6 women and 1 man, ranging in
age from 7 to 44 years (mean age, 26.5 years).The primary
lesion was osteosarcoma in 4, and PNET, GCT (grade 3),
and synovial sarcoma in one each. The duration of follow-
up after the initial examination ranged from 12 to 19 years
(mean: 16 years). The prosthesis model, replacement site,
stem diameter, length of resected bone, resection rate, and
ISOLS X-ray evaluation were investigated in all 40 cases.
In the 7 cases undergoing revision, conditions and back-
ground factors at the time of breakage, breakage site, time
of revision, models of previous and new prostheses, stem
diameters before and after revision, details of the revision
(blood loss, operative time, surgical procedure), and the
presence or absence of adjuvant therapy were also investi-
gated. In addition, ISOLS X-ray and functional evalua-
tions were performed before revision and at the Wnal
follow-up.
Results
Replacement site and time of revision
The prosthesis replacement site was the distal femur in 28
and the proximal tibia in 12 cases. Among the 7 cases
requiring revision due to stem breakage or loosening, the
replacement site was the distal femur in 5 and the proximal
tibia in 2. The shortest and longest times until revision for
breakage and loosening, after the initial wide resection fol-
lowed by reconstruction of the tumor aVected limb or an
elongation-type prosthesis placement, were 10 months and
11 years, respectively, with a mean of 6 years and
2 months.
Prosthesis models used in the initial replacement 
and the revision
At the initial replacement in our 40 cases, the Howmedica
Modular Reconstruction System (HMRS) was used in 22,
and the rotating hinge type in two. The Kotz Modular
Femur and Tibia Reconstruction System (KMFTR) was
used in 6, the Growing Kotz in 10, the Kyocera custom-
made prosthesis in one, and the Kyocera PH1 (physio-hinge
type 1) in one. The broken models in the 7 revision cases
were the KMFTR in 4, and HMRS and physio-hinge type I
in one each. Revision for loosening of the stem was per-
formed in a 7-year-old female with PNET who had under-
gone reconstruction of the distal femur with a Growing
Kotz (Case 2). The model used for revision was the HMRS
in 3 cases reconstructed with a KMFTR at the initial
replacement excluding a proximal tibial case (Case 2). In
Case 38, a PH type 1 with an 11-mm stem diameter was
changed to the slightly thicker PH type 2 with a 12-mm
stem diameter. In Case 39, the stem diameter (12 mm) of
the new prosthesis was the same as that before breakage.
However, the new stem, at 15 cm, was longer. In Case 2, a
new component was prepared, considering that the tibial
component of the HMRS employed for adults is too large.
The new tibial component was designed with proximal and
distal diameters of 15 and 10 mm, respectively, and a stem
length of 14 cm, and the stem was entirely covered with a
porous coating (Tables 1, 2).
Stem diameter
The stem diameters ranged from 8 to 14 mm (mean:
11.1 mm) in our 40 cases. In the non-revision cases, they
ranged from 8 to 14 mm (mean: 11.2 mm). In the revision
cases, the diameters ranged from 9 to 12 mm (mean:
10.2 mm), the diameter of the broken KMFTR was 10 mm
in all 4 cases. The prosthesis was changed to one with a
stem diameter of 12 mm in 3 of these 4 cases. In Case 39,Eur J Orthop Surg Traumatol (2012) 22:387–394 389
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the stem diameter (12 mm) of the new prosthesis was the
same as that of the broken one, but the new stem was longer
(15 cm). In Case 2, the stem region of the tibial component
of the Growing Kotz employed in the initial replacement
had proximal and distal stem diameters of 12 and 9 mm,
respectively, and a length of 10 cm. On revision, it was
replaced with a new porous-coated tibial component with
proximal and distal diameters of 15 and 10 mm, respec-
tively, and a length of 14 cm. Screw breakage was noted in
Cases 37 and 39.
Table 1 List of cases with reconstruction of regions around the knee joint using prostheses
DF distal femur, PT proximal femur, HMRS Howmedica Modular Resection System, KMFTR Kotz Modular Femoral and Tibia Replacement,
PH type 1 physio-hinge type 1, PH type 2 physio-hinge type 2
Case Age Gender Pathological 
diagnosis
Model Replacement 
site
Resected 
length (cm)
Stem diameter 
(mm)
Resection 
rat (%)
1 7 M OS Growing Kotz DF 14 8 36.80
2 7 F PNET Growing Kotz DF 21 9 53
3 11 M OS Growing Kotz DF 13 11 33
4 16 F OS Growing Kotz DF 13 10 31
5 10 F OS Growing Kotz DF 15 9 45
6 12 M OS Growing Kotz DF 17 10 44
7 8 M OS Growing Kotz PT 12 10 50
8 12 M Ewing sarcoma Growing Kotz PT 15 10 35
9 16 F OS Growing Kotz PT 10 10 33
10 12 F OS Growing Kotz PT 16 10 32
11 34 M OS HMRS PT 16 12 47
12 60 F OS HMRS DF 16 14 38
13 57 F Chondrosarcoma HMRS DF 12 11 35
14 18 F OS HMRS PT 12 12 34
15 57 F Chondrosarcoma HMRS (Rotating) DF 12 12 26
16 27 F OS HMRS DF 18 13 39
17 25 M OS HMRS DF 17 13 34
18 24 M OS HMRS PT 13 11 37
19 12 F OS HMRS DF 18.5 12 42
20 20 M MFH of bone HMRS PT 14.5 11 47
21 25 M OS HMRS (Rotating) DF 12 12 27
22 27 M OS HMRS DF 16 12 33
23 56 F Chondrosarcoma HMRS PT 18 12 47
24 16 M OS HMRS DF 12 10 30
25 13 M OS HMRS DF 16 12 27
26 18 M OS HMRS DF 14 12 43
27 20 M OS HMRS DF 12 13 29
28 66 F MFH of bone KMFTR DF 12 11 27
29 82 M Chondrosarcoma KMFTR DF 16 12 34
30 27 M OS HMRS PT 17 11 45
31 52 F OS Kyocera (cement) DF 16 11 35
32 50 M Chondrosarcoma HMRS DF 18 11 48
33 41 M GCT HMRS PT 13 12 40
34 44 F OS KMFTR DF 12 10 23
35 31 F OS KMFTR PT 12 10 34
36 26 F OS KMFTR DF 23 10 54
37 40 F Synovial sarcoma KMFTR DF 14 10 48
38 15 M OS PH type1 (cement) DF 18 11 55
39 28 F OS HMRS DF 22 12 48
40 66 F MFH of bone HMRS DF 18 12 38390 Eur J Orthop Surg Traumatol (2012) 22:387–394
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Resected bone length
The respective maximum and minimum lengths of resected
bone including the tumor region were 12 and 23 cm, with a
mean of 15.4 cm. Those in the 33 non-revision cases were
10 and 18.5 cm, respectively, with a mean of 14.6 cm. In
the 7 revision cases, these lengths were 12 and 22 cm,
respectively, with a mean of 17.7 cm (Table 1).
Resection rate of aVected bone
The resected region accounted for 27–50% (mean: 36) in the
33 non-revision cases, and 23–53% (mean: 45%) in the 7
revision cases. Thus, the ratio of the resected region was
greater, comprising nearly half of the aVected bone, in cases
undergoing revision for breakage or loosening (Table 1).
Conditions and backgrounds of patients at the time 
of breakage
The stem was broken in 6 patients. Five had experienced
sudden pain in the femoral or knee joint regions, while
walking. They visited our hospital, and breakage was iden-
tiWed on X-ray examination. In the other patient (Case 39),
dull pain appeared in the proximal femoral region and had
become severe about 4 months later. At this time, breakage
was identiWed. Only this patient was actively engaged in
activities such as dancing and mountain climbing, while the
other 6 were not especially involved in athletic activities.
Regarding the social backgrounds of these 7 patients, Cases
34–37 were housewives, Case 38 was a clerical employee,
mainly working at a desk, Case 39 was a speech therapist,
and Case 2 was a student.
ISOLS X-ray and functional evaluations
X-ray evaluation was performed at the Wnal follow-up in all
40 cases, and all items pertaining to bone remodeling, inter-
face, and anchorage were graded as excellent in about 70%
of these patients. However, in the revision group, the inter-
face before revision was graded as poor and fair in Cases 2
and 39, respectively, and anchorage was graded as fair in
all cases. After revision, bone remodeling was graded as
poor only in Case 38, in whom the bone cortex around the
stem was thinned by more than 1/3. A radiolucent line was
also noted in the interface, resulting in a grading of fair.
Functional evaluation was performed before revision and at
the Wnal postrevision follow-up. The evaluation was 53–
80% (mean: 70.1%) before and 63–86% (mean: 76.2%)
after revision (Table 3).
Table 2 Revision cases managed by our department
Case Age Sex Location Time of revision 
(mon) (m)
Type Diameter 
(mm)
Screw 
breakage
Type of new 
prosthesis
Diameter
Case 34 44 F Distal femur 48 KMFTR 10 ¡ HMRS 12 mm
Case 35 31 F Proximal tibia 84 KMFTR 10 ¡ KMFTR 10 mm
Case 36 26 F Distal femur 10 KMFTR 10 ¡ HMRS 12 mm
Case 37 40 F Distal femur 28 KMFTR 10 + HMRS 12 mm
Case 38 15 M Distal femur 108 PH type1 11 ¡ PH type 2 12 mm
Case 39 28 F Distal femur 132 HMRS 12 + HMRS 12 mm
Case 2 7 F Proximal tibia 113 Growing Kotz Proximal: 12
Distal: 9
¡ Growing Kotz Proximal: 15 m
Distal: 10 mm
Table 3 Functional and radio-
logical assessments and the 
presence/absence of adjuvant 
therapy before and after 
replacement
Functional assessment Radiographical assessment
Case Before 
replacement (%)
After 
replacement (%)
Before replacement After replacement
Bone remodeling/
interface/
anchorage
Bone remodeling/
interface/
anchorage
Case 34 78 80 E/G/F G/G/E
Case 35 75 78 E/G/F G/G/E
Case 36 76 73 E/E/F F/E/E
Case 37 73 74 G/G/F G/G/E
Case 38 80 63 G/G/F P/F/G
Case 39 60 80 G/F/F G/G/E
C a s e  2 5 38 6G / P / F E / E / E E excellent, G good, F failure, 
P poorEur J Orthop Surg Traumatol (2012) 22:387–394 391
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Details of revision (blood loss and operative time)
The shortest and longest operative times in the 7 cases were
3 h and 20 min and 6 h and 11 min, respectively, with a
mean of 4 h and 7 min. The minimum and maximum blood
losses were 155 and 600 g (mean: 369 g), respectively
(Table 4).
Presence or absence of adjuvant therapy
Case 33 in the revision group was diagnosed with a grade 3
GCT of the bone, and underwent surgery alone. Pre- and
postoperative chemotherapies were administered in the
other 6 cases. In Case 2, radiotherapy (50 Gy) was addi-
tionally performed for local control, after the completion of
preoperative chemotherapy (Table 4).
Discussion
Recent advancements in surgical approaches and chemo-
therapy for primary malignant bone tumors have increased
survival rates. The usefulness of reconstruction methods for
aVected limbs, including prostheses, has also been con-
Wrmed. However, complications associated with prostheses,
such as infection, loosening, and breakage, remain prob-
lematic. Regarding stem breakage, in 1994, Capanna et al.
[6] reported that stem breakage occurred in 6 (6.3%) of 95
cases treated with modular uncemented tumor prostheses.
In 2001, Mittenmayer et al. [5] reported that major compli-
cations occurred in 19 of 100 cases with uncemented tumor
prostheses, 11 of these involved aseptic loosening, and sep-
tic loosening and implant fracture occurred in 4 each. In
2006, Gosheger reported that stem breakage occurred in 4
(1.6%) of 250 cases with uncemented tumor prostheses [7].
In our department, breakage occurred after 5 years and
6 months on average, with the earliest being 10 months and
latest 11 years. The models used were the KMFTR in 4 and
the HMRS and PH type 1 in one case each. The stem diam-
eters of 10 mm in 4 and 11 mm in one case were relatively
thin for distal femoral stems. After revision, the stem diam-
eter was 10 mm in only one, being thicker in all other cases.
Although increased activity of patients and stem loosening
were considered to be the causes of stem breakage, the
design of the prostheses may have contributed to breakage,
because the prostheses generally had a hinge-type structure
[8]. In 2005, GriYn et al. reported that the incidence of
KMFTR stem breakage involving the proximal tibia rose
when the stem diameter was small, and the length of
resected bone increased. They also described cases of distal
femoral replacement: the 5-year survival rates were 35, 85,
and 71.2% in patients in whom the distal femoral stem sizes
were 10–12, 13, and 14–16 mm, respectively. These obser-
vations showed that the stem diameter, rather than the
resection length, was related to breakage in cases undergo-
ing distal femoral replacement. We also focused on the
stem diameter and the length of resected bone. We investi-
gated the stem diameter and resection rate in all 40 cases.
The mean stem size of 10.2 mm in the revision cases and
11.2 mm in the non-revision cases conWrmed that a thin
stem was used in the revision cases. Currently, 11–15-mm
straight types and 12–15-mm curved types of diaphysis-
Wxing pieces are available for HMRS.
All stems with a 10-mm diameter are of the Growing
Kotz and KMFTR types. In cases reconstructed with the
HMRS, stems with a relatively small diameter, 11 or
12 mm, were used in 80%. This may reXect the Japanese
physique. The mean resection rate was 34.7% in the non-
revision and 45% in the revision cases. The length of
resected bone was thus greater in the revision than in the
non-revision cases. When the resection rate is almost 45%
in the clinical setting, possible reconstruction methods
other than the use of a tumor prosthesis include total femo-
ral replacement and biological reconstruction [3,  9,  10].
However, these reconstruction methods are indicated in
only limited cases. When a tumor prosthesis is used, atten-
tion should be paid to the bone resection rate.
Comparison by region, such as the femoral and proximal
tibial regions, was not possible because of the small num-
ber of cases. However, we would not expect more stress to
be loaded on a thin stem used for a region from which a
large amount of bone was excised. GriYn et al. also
reported that stem breakage occurred in 6 (6.1%) of 99
cases reconstructed with the KMFTR. These breakages
occurred at 3 holes in the stem, indicating a structural prob-
lem. They stated that the ideal design of a prosthesis may
be a strong and thick stem without holes to stop lateral
movement, which facilitates bone ingrowth comparable or
superior to that around the KMFTR stem. Aseptic loosen-
ing of the stem may be another cause of stem breakage. In
our 40 patients, loosening was apparently present at the
interface, being graded as poor in Cases 2 and 8 with a
Growing Kotz. It was also graded as poor in Case 15, a
Table 4 Adjuvant therapy and details of revision surgery
Case Adjuvant 
therapy
Blood 
loss (g)
Operation 
time (min)
Case 34 + 430 200
Case 35 ¡ 370 260
Case 36 + 282 212
Case 37 + 330 240
Case 38 + 155 210
Case 39 + 600 220
Case 2 + 420 371392 Eur J Orthop Surg Traumatol (2012) 22:387–394
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57-year-old female with distal femoral chondrosarcoma in
whom a rotating hinge-type HMRS was applied. The inci-
dence of aseptic loosening varies among reports, ranging
from as low as 1 and 5% up to 26 and 29% [11–18]. In
2001, Mittermayer et al. reported that aseptic loosening
occurred in 27% of cases with complications involving
stems [5]. In 1990, they developed an anatomically curved
stem, which Wt in the femoral bone marrow cavity to avoid
stress shielding generated by Wrm Wxation around the stem.
Then in 1996, they rotated the hinge-type HMRS. The inci-
dence of aseptic loosening in cases receiving this type of
prosthesis was approximately 10% during a 42–134-month
follow-up period. Aseptic loosening is considered to be
related to a patient’s activity level. However, only in our
Case 39 (28-year-old female) in the revision group had a
high activity level, i.e., such a tendency was not apparent in
our patients. Functional and X-ray evaluations following
revision were favorable over the short, medium, and long
term in various reports [6, 11, 14, 17]. A similar tendency
was noted in our patients. However, a 40-mm leg length
discrepancy remained after surgery in our Growing Kotz-
revised cases, resulting in a functionally unsatisfactory out-
come.
We experienced 6 cases requiring revision for stem
breakage. The shortest and longest operative times in the 7
revision cases were 3 h and 20 min and 6 h and 11 min,
respectively, with a mean of 4 h and 7 min, and the mini-
mum, maximum, and mean blood losses were 155, 600, and
369 g, respectively. The levels of surgical stress may have
been similar to that in the Wrst wide resection with regard to
the operative time and blood loss. Tang and Sim reported
the revision procedures for stem breakage [19,  20]. The
goals of distal femoral revision are to cut-oV the femoral
bone cortex using a Surge Airtome or drill following the
shape of the stem. This requires great care to avoid break-
age of the cut-out bone cortex upon removal of the broken
stem. A new stem must also be inserted, followed by
returning the cut-oV bone cortex block to its original posi-
tion. Concerning reaming, we ream the femoral medullary
cavity to a diameter 1 mm larger than that determined by
preoperative measurement in principle. However, when the
medullary cavity is narrow, reaming is performed to the
stem diameter selected based on preoperative measurement.
When a trial stem can be inserted, the real stem is inserted.
When a trial stem cannot be inserted, over-reaming by
1 mm is performed. In revision surgery, since a thicker
stem is inserted, over-reaming by 1 mm is always per-
formed. Firm Wxation is then with a cable. At this point, it is
also necessary to add autologous or artiWcial bone grafting
to assure suYcient future strength [21] (Figs. 1, 2).
Based on the above observations, stem size, shape, and
porous coating serve as countermeasures against stem
breakage, as does bone grafting to the bone stump and
preservation of the periosteum [5, 11]. However, no ideal
prosthesis has as yet been established, though many
researchers have investigated and developed various prom-
ising models [11]. Based on this study, we consider the fol-
lowing points to be important for avoiding prosthetic stem
breakage: (1) Minimizing the length of bone resected, i.e.,
it is desirable not to exceed one third of the aVected bone by
employing a limited operation, and (2) selection of a stem
diameter of at least 12 mm. For the femur, the use of a
Fig. 1 The residual stem in the femur was carefully cut oV using a
Surge Airtome or chisel. It is important to carefully remove the broken
stem because of intense bone ingrowth. Attention should also be paid
to avoiding breakage of the fenestrated bone fragment and to return it
to the original position after placement of the new stem
Fig. 2 After placement of the new stem, bone grafting is performed
around the stem as shown. The use of a cable should also be considered
for achieving stronger WxationEur J Orthop Surg Traumatol (2012) 22:387–394 393
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curved stem should be investigated in consideration of the
anatomical shape of this bone.
Regarding limb salvage for malignant bone tumors in
children, an elongation-type prosthesis can be lengthened to
correspond to the predicted leg length discrepancy, when
employed for wide resection of a periarticular tumor includ-
ing the joint [22–30]. A characteristic of the elongation-type
Growing Kotz is the porous coating on the diaphysis-Wxing
piece of the elongation region. In contrast, non-porous pro-
cessing is added to the non-elongation region. However,
this structure may create susceptibility to loosening. When
a pediatric patient grows more than expected, particularly,
in the transverse axis of the proximal tibia, loosening and
burying of the stem start and slowly progress. This ulti-
mately, compresses the bone cortex. Although the Growing
Kotz can be elongated with growth, the prosthetic design,
particularly the width of the tibial component, should be
suYciently investigated in consideration of the child’s
development.
Conclusion
Prosthesis use facilitates the early acquisition of stable
functioning of the aVected limb, but several complications
have yet to be overcome. Breakage and loosening necessi-
tate revision in some cases. Methods considered to reduce
the risk of prosthesis breakage, include limiting resection of
the aVected bone to no more than 30% and adoption of as
thick a stem as possible, i.e., with a diameter of at least
12 mm,  Wtting the anatomical shape of the femur. The
unchanged function of the aVected limb after revision and
instructing of patients to avoid excessive exercise in daily
activities are also important for maintenance of prostheses.
Although only the elongation-type of Growing Kotz is cov-
ered by the national health insurance system in Japan, this
prosthesis should also be selected with care, taking the
child’s future development into consideration.
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